StockData
Xenetic Biosciences, Inc. logo

Xenetic Biosciences, Inc. (XBIO) stock

XBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3064% below fair value
$1.61+0.12 (+8.05%)

Close on Nov 17, 2026Market cap $3.77MP/E –Yield –

Xenetic Biosciences total assets

Total assets on the balance sheet at the end of each period.

Xenetic Biosciences's total assets was $6.97M at Jun 30, 2026. For fiscal 2025 it was $8.36M, up 21.2% from the year before. Over ten years it grew -6.8% a year on average. The highest annual figure on record is $25.37M in fiscal 2012.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$8.36M+21.2%
FY2024Dec 31, 2024$6.90M-34.9%
FY2023Dec 31, 2023$10.61M-28.0%
FY2022Dec 31, 2022$14.72M-25.7%
FY2021Dec 31, 2021$19.82M+50.3%
FY2020Dec 31, 2020$13.18M-38.8%
FY2019Dec 31, 2019$21.55M+49.3%
FY2018Dec 31, 2018$14.43M-24.7%
FY2017Dec 31, 2017$19.16M-8.6%
FY2016Dec 31, 2016$20.97M+24.0%
FY2015Dec 31, 2015$16.91M+3.6%
FY2014Dec 31, 2014$16.32M-16.2%
FY2013Dec 31, 2013$19.47M-23.3%
FY2012Dec 31, 2012$25.37M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.97M+30.2%
Q1 FY2026Mar 31, 2026$7.91M+36.6%
Q4 FY2025Dec 31, 2025$8.36M+21.2%
Q3 FY2025Sep 30, 2025$5.07M-37.0%
Q2 FY2025Jun 30, 2025$5.35M-40.7%
Q1 FY2025Mar 31, 2025$5.79M-38.4%
Q4 FY2024Dec 31, 2024$6.90M-34.9%
Q3 FY2024Sep 30, 2024$8.05M-32.7%
Q2 FY2024Jun 30, 2024$9.03M-29.1%
Q1 FY2024Mar 31, 2024$9.39M-31.5%
Q4 FY2023Dec 31, 2023$10.61M-28.0%
Q3 FY2023Sep 30, 2023$11.96M-27.4%
Q2 FY2023Jun 30, 2023$12.75M-29.1%
Q1 FY2023Mar 31, 2023$13.72M-30.8%
Q4 FY2022Dec 31, 2022$14.72M-30.8%
Q2 FY2022Jun 30, 2022$16.47M+50.9%
Q1 FY2022Mar 31, 2022$17.98M+52.9%
Q4 FY2021Dec 31, 2021$19.82M+50.3%
Q3 FY2021Sep 30, 2021$21.29M+144.8%
Q2 FY2021Jun 30, 2021$10.92M-42.7%
Q1 FY2021Mar 31, 2021$11.76M-43.0%
Q4 FY2020Dec 31, 2020$13.18M-38.8%
Q3 FY2020Sep 30, 2020$8.70M-62.0%
Q2 FY2020Jun 30, 2020$19.06M+21.9%
Q1 FY2020Mar 31, 2020$20.63M+25.3%
Q4 FY2019Dec 31, 2019$21.55M+49.3%
Q3 FY2019Sep 30, 2019$22.88M+47.3%
Q2 FY2019Jun 30, 2019$15.63M-9.4%
Q1 FY2019Mar 31, 2019$16.46M-6.2%
Q4 FY2018Dec 31, 2018$14.43M-24.7%
Q3 FY2018Sep 30, 2018$15.53M+6.1%
Q2 FY2018Jun 30, 2018$17.26M+5.0%
Q1 FY2018Mar 31, 2018$17.54M-6.8%
Q4 FY2017Dec 31, 2017$19.16M-8.6%
Q3 FY2017Sep 30, 2017$14.64M+5.6%
Q2 FY2017Jun 30, 2017$16.44M+24.9%
Q1 FY2017Mar 31, 2017$18.83M–
Q4 FY2016Dec 31, 2016$20.97M–
Q3 FY2016Sep 30, 2016$13.87M–
Q2 FY2016Jun 30, 2016$13.16M–

More Xenetic Biosciences figures

See a number that looks wrong?